Validation issues

The validation umbrella not only covers in-house systems, but also covers vendor systems. Much of industry today is dependent to some extent on vendor-supplied electronic systems and, consequently, the vendor s validation of those systems. Because of this, there are validation issues to assess at the vendor including how the vendor addresses change control, testing and documentation, source code, integration, and implementation of the system during development. Implementation support also must be assessed. 

Identify available information, including information from quality control charts, performance in proficiency testing rounds, literature and validation information on related methods and data concerning comparison with other methods. Use the available information and professional judgement to review each relevant validation issue and sign-off issues adequately addressed and documented. 

Disadvantages Cells only grow when attached to solid substrates cells require additional attachment factor not easy to scale up more cleaning validation issues and high disposal cost more difficult to operate than suspension process... 

Because of their importance, validation issues have been addressed by several organizations and private authors ... 

Qualification and validation issues with respect to a new product/pro-... 

Nusch, K. Validation issues for OTC drug manufacturers. Global Cos Ind March 34-38 (2000). 

Filters are used for clarification, removal of small molecules, exchange of buffers, and concentration of product, as well as sterilization and virus removal. A recent review of validation of filtration describes the critical validation issues [29], Filter compatibility is tested with process conditions to avoid nonspecific binding of product to the filter or addition of extractables to the process stream. Extractables are defined and limits established based on final product safety studies. Special considerations apply for sterilizing filters and those that are designed for virus removal. These filters are single use, however, which simplifies the validation effort. 

Regulatory authorities do not generally inspect these systems instead they inspect individual training records. Such systems should, however, be validated to ensure their reliability and performance. Specific validation issues to be addressed include "... 

The repository may range from a specific directory on a server, with a work group password protection, to a software package-controlled database repository implementing full database security controls. There may also be a requirement to produce and store multiple renditions of a document within the repository. Specific validation issues include ... 

Validation issues The analysis data usually form part of the manufacturing batch records. Consideration must be given to a Suppher Audit, and this will include a formal software audit if the analyzer is controlled by a computer system. The design and testing of the analyzer computer system (apphcation software and hardware) will need to follow a formal, hfe-cycle methodology. ... 

Danger, L.J. (1993). Validation issues and the development of new product assays stressed at BioEasf93. Genetic Engineering News 13, Debruary 15, 1 28. 

The validation issue for ID, 2D, and 3D descriptors for similarity searching and virtual... 

Sweeney, M. Davenport, S. Edwards, L. Validation Issues for a Product Barrier/Isolator Sterile Liquid Filling System in a Controlled Environment, Proceedings of PDA/ISPE Conference on Advanced Barrier Technology, 1995. 

As for all bioanalytical methods applied to support of drug development, validation of immunoassays is important. However, several validation issues need special attention for immunoassays. These include stability of the critical reagents, the curvilinear nature of the calibration curve, the greater variability of immunoassays, and, particularly important, the specificity of the assay. 

For an analytical method to deliver valid analytical results, proper characterization and validation of the method is necessary. In dmg development, and especially with respect to preclinical and clinical studies, the generated data will be part of the submission files for approval and registration of the new dmg. This means that GLP and FDA guidelines must be fulfilled [6]. Obviously, validation issues are dealt with differently in dmg discovery stages, as compared to preclinical and chnical trials. 

The use of two SRM transitions, one with an intense fragment ion for the low end of the calibration and one with a less intense fragment ion for the high end, has been proposed to expand the linear dynamic range of a bioanalytical method [34]. Proper attention has to be paid to validation issues related to this approach. 

---